Cat.#: ACPP-1273
Despition | BTB/POZ domain-containing protein 7 Blocking Peptide for Immmunodepletion, Competition Assay |
SIZE | 250 µg |
Applications | Immunodepletion & Immunocompetition assay |
Storage | Store at -20⁰C for long term |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1207 | Dopamine Receptor D1 Blocking Peptide (AC1207) | 250 µg | inquiry |
ACPP-1647 | Human TUBB3 Protein (AC1647) | 2 µg | inquiry |
ACPP-1049 | Recombinant Human Galectin 3 Protein (6×His Tag) (AC1049) | 50 µg | inquiry |
ACPP-1381 | Human DTNBP1 Protein (AC1381) | 5 µg | inquiry |
ACPP-1707 | Human RAB5B Protein (AC1707) | 5 µg | inquiry |
ACPP-1260 | iNOS Blocking Peptide (AC1260) | 250 µg | inquiry |
ACPP-1098 | Synthetic Nanodisc Human CD133 Protein (AC1098) | 10 µg | inquiry |
ACPP-1773 | Human LIN28 Protein (AC1773) | 2 µg | inquiry |
ACPP-1217 | P2Y2 Blocking Peptide (AC1217) | 250 µg | inquiry |
ACPP-1569 | Human SOX2 Protein (AC1569) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.